Literature DB >> 21418177

Integrated profiling of diffuse large B-cell lymphoma with 7q gain.

Ekaterina Chigrinova1, Michael Mian, Yulei Shen, Timothy C Greiner, Wing C Chan, Julie M Vose, Giorgio Inghirami, Annalisa Chiappella, Luca Baldini, Maurilio Ponzoni, Andrés J M Ferreri, Silvia Franceschetti, Gianluca Gaidano, Alessandra Tucci, Fabio Facchetti, Thierry Lazure, Olivier Lambotte, Santiago Montes-Moreno, Miguel A Piris, Emanuele Zucca, Ivo Kwee, Francesco Bertoni.   

Abstract

To characterize diffuse large B-cell lymphoma (DLBCL) with chromosome 7 gains, we combined clinical data with genomic, RNA and miRNA profiling. Gains were associated with age >60 years, female gender, a trend for higher complete response rate, lower death rate, and better overall survival in patients treated with R-CHOP. Lesions were inversely associated with bone marrow involvement and number of extra-nodal sites. Differentially expressed transcripts were enriched of genes belonging to specific pathways and miRNAs targets. MIR96, MIR182, MIR589, MIR25 were shown significantly up-regulated in 7q+ DLBCL by real-time PCR.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21418177     DOI: 10.1111/j.1365-2141.2011.08628.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Cross-platform assessment of genomic imbalance confirms the clinical relevance of genomic complexity and reveals loci with potential pathogenic roles in diffuse large B-cell lymphoma.

Authors:  Lizalynn M Dias; Venkata Thodima; Julia Friedman; Charles Ma; Asha Guttapalli; Geetu Mendiratta; Imran N Siddiqi; Sergei Syrbu; R S K Chaganti; Jane Houldsworth
Journal:  Leuk Lymphoma       Date:  2015-11-16

Review 2.  New insights into MicroRNAs involves in drug resistance in diffuse large B cell lymphoma.

Authors:  Xin Yu; Zheng Li
Journal:  Am J Transl Res       Date:  2015-12-15       Impact factor: 4.060

3.  Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma.

Authors:  Karina A Galoian; Toumy Guettouche; Biju Issac; Amir Qureshi; H T Temple
Journal:  Tumour Biol       Date:  2013-11-01

4.  Granulocyte colony-stimulating factor produces long-term changes in gene and microRNA expression profiles in CD34+ cells from healthy donors.

Authors:  Alicia Báez; Beatriz Martín-Antonio; José I Piruat; Concepción Prats; Isabel Álvarez-Laderas; M Victoria Barbado; Magdalena Carmona; Álvaro Urbano-Ispizua; Jose Antonio Pérez-Simón
Journal:  Haematologica       Date:  2013-09-20       Impact factor: 9.941

Review 5.  Genetic lesions in diffuse large B-cell lymphomas.

Authors:  M Testoni; E Zucca; K H Young; F Bertoni
Journal:  Ann Oncol       Date:  2015-01-20       Impact factor: 32.976

Review 6.  Alkylating anticancer agents and their relations to microRNAs.

Authors:  Bernhard Biersack
Journal:  Cancer Drug Resist       Date:  2019-03-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.